Published in J Clin Invest on June 01, 2003
Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J Clin Invest (2009) 2.55
Molecular imaging with optics: primer and case for near-infrared fluorescence techniques in personalized medicine. J Biomed Opt (2008) 1.94
Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expression. Nat Med (2010) 1.81
Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil. Proc Natl Acad Sci U S A (2005) 1.65
Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging. FASEB J (2005) 1.52
Tetrazine-trans-cyclooctene ligation for the rapid construction of integrin αvβ₃ targeted PET tracer based on a cyclic RGD peptide. Bioorg Med Chem Lett (2011) 1.36
Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium. Circulation (2004) 1.33
Long term non-invasive imaging of embryonic stem cells using reporter genes. Nat Protoc (2009) 1.27
Visualization of a primary anti-tumor immune response by positron emission tomography. Proc Natl Acad Sci U S A (2005) 1.26
Proteomic analysis of reporter genes for molecular imaging of transplanted embryonic stem cells. Proteomics (2006) 1.24
Therapeutic procedures for submucosal tumors in the gastrointestinal tract. World J Gastroenterol (2007) 1.22
Diagnostic procedures for submucosal tumors in the gastrointestinal tract. World J Gastroenterol (2007) 1.16
Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging. J R Soc Interface (2010) 1.16
Tyrosinase as a multifunctional reporter gene for Photoacoustic/MRI/PET triple modality molecular imaging. Sci Rep (2013) 1.10
Pulsed magneto-motive ultrasound imaging using ultrasmall magnetic nanoprobes. Mol Imaging (2011) 1.07
Non-invasive imaging of cardiac transgene expression with PET: comparison of the human sodium/iodide symporter gene and HSV1-tk as the reporter gene. Eur J Nucl Med Mol Imaging (2005) 1.03
Translational molecular imaging for cancer. Cancer Imaging (2005) 0.93
Recent development in PET instrumentation. Curr Pharm Biotechnol (2010) 0.92
Human gene therapy and imaging: cardiology. Eur J Nucl Med Mol Imaging (2005) 0.88
Noninvasive imaging of cell-mediated therapy for treatment of cancer. J Nucl Med (2008) 0.88
The evolution of imaging in cancer: current state and future challenges. Semin Oncol (2011) 0.87
Musculoskeletal molecular imaging: a comprehensive overview. Trends Biotechnol (2010) 0.86
Tracking of dendritic cell migration into lymph nodes using molecular imaging with sodium iodide symporter and enhanced firefly luciferase genes. Sci Rep (2015) 0.86
New strategy for monitoring targeted therapy: molecular imaging. Int J Nanomedicine (2013) 0.85
In vivo non invasive molecular imaging for immune cell tracking in small animals. Immune Netw (2012) 0.82
Tumor-specific expression and detection of a CEST reporter gene. Magn Reson Med (2015) 0.82
Molecular-genetic imaging of cancer. Adv Cancer Res (2014) 0.81
Principles and basic concepts of molecular imaging. Pediatr Radiol (2010) 0.79
Cancer imaging: Gene transcription-based imaging and therapeutic systems. Int J Biochem Cell Biol (2012) 0.77
Molecular imaging of pulmonary gene expression with positron emission tomography. Proc Am Thorac Soc (2005) 0.77
Imaging and biological function in health and disease. J Clin Invest (2003) 0.77
Imaging of human sodium-iodide symporter gene expression mediated by recombinant adenovirus in skeletal muscle of living rats. Eur J Nucl Med Mol Imaging (2004) 0.77
In Vivo Measurements of Tumor Metabolism and Growth after Administration of Enzastaurin Using Small Animal FDG Positron Emission Tomography. J Oncol (2009) 0.76
Visualization of the Biological Behavior of Tumor-Associated Macrophages in Living Mice with Colon Cancer Using Multimodal Optical Reporter Gene Imaging. Neoplasia (2016) 0.76
Imaging virus-associated cancer. Curr Pharm Des (2008) 0.75
Is the future of nuclear medicine written in the genes? Eur J Nucl Med Mol Imaging (2004) 0.75
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med (2002) 24.88
The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem (1977) 11.55
The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation. Mol Cell Biol (2002) 7.44
The CD28 signaling pathway regulates glucose metabolism. Immunity (2002) 6.65
In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol (2000) 5.49
Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med (1990) 5.27
Bioluminescent indicators in living mammals. Nat Med (1998) 4.71
HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science (1997) 4.58
Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet (1995) 4.07
Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol (1997) 3.47
A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci U S A (2000) 3.28
Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia (2001) 2.97
Visualizing the kinetics of tumor-cell clearance in living animals. Proc Natl Acad Sci U S A (1999) 2.76
Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci U S A (1999) 2.71
Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J Nucl Med (1998) 2.58
Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res (1998) 2.55
Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. Cancer Res (1996) 2.22
Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther (1999) 2.21
Imaging the expression of transfected genes in vivo. Cancer Res (1995) 2.05
Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci U S A (2002) 2.01
Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet (2001) 1.94
Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes. Nat Biotechnol (2003) 1.87
Noninvasive quantitative imaging of protein-protein interactions in living subjects. Proc Natl Acad Sci U S A (2002) 1.85
Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters. Proc Natl Acad Sci U S A (2001) 1.85
Noninvasive imaging of protein-protein interactions in living animals. Proc Natl Acad Sci U S A (2002) 1.81
Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J Nucl Med (2002) 1.72
Noninvasive imaging of c-myc oncogene messenger RNA with indium-111-antisense probes in a mammary tumor-bearing mouse model. J Nucl Med (1994) 1.59
Quantification of target gene expression by imaging reporter gene expression in living animals. Nat Med (2000) 1.56
MR imaging and scintigraphy of gene expression through melanin induction. Radiology (1997) 1.38
Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo. Neoplasia (2002) 1.36
Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: clinical follow-up and improved new vectors. Hum Gene Ther (1998) 1.34
Viral vector systems for gene therapy. Cancer Gene Ther (1994) 1.32
A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase. Neoplasia (1999) 1.25
Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Cancer Res (1999) 1.24
Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. Proc Natl Acad Sci U S A (2001) 1.22
Correlation between 99mTc-pertechnetate uptakes and expressions of human sodium iodide symporter gene in breast tumor tissues. Nucl Med Biol (2001) 1.20
Tumor-specific transcriptional targeting of suicide gene therapy. Gene Ther (2002) 1.16
"Facilitated" amino acid transport is upregulated in brain tumors. J Cereb Blood Flow Metab (1998) 1.15
Measurement of local cerebral glucose metabolism in man with 18F-2-fluoro-2-deoxy-d-glucose. Acta Neurol Scand Suppl (1977) 1.15
In vivo imaging of oligonucleotides with positron emission tomography. Nat Med (1998) 1.15
Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Cancer Res (2001) 1.12
An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression. Mol Ther (2001) 1.10
Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer. Nat Med (2001) 1.08
Translational regulation of the synthesis of dihydrofolate reductase. Adv Exp Med Biol (1993) 0.94
Receptor-targeted co-transport of DNA and magnetic resonance contrast agents. Chem Biol (1995) 0.94
Imaging expression of cytosine deaminase-herpes virus thymidine kinase fusion gene (CD/TK) expression with [124I]FIAU and PET. Mol Imaging (2003) 0.90
Cells exposed to antifolates show increased cellular levels of proteins fused to dihydrofolate reductase: a method to modulate gene expression. Proc Natl Acad Sci U S A (2002) 0.88
Gene transfer strategies for improving radiolabeled peptide imaging and therapy. Q J Nucl Med (2000) 0.87
Clinical evaluation of adenoviral-mediated p53 gene transfer: review of INGN 201 studies. Semin Oncol (2001) 0.86
Gene therapy with sodium/iodide symporter in hepatocarcinoma. Exp Clin Endocrinol Diabetes (2001) 0.85
Monitoring of spatial expression of firefly luciferase in transformed zebrafish. J Biolumin Chemilumin (1996) 0.85
MR receptor imaging: ultrasmall iron oxide particles targeted to asialoglycoprotein receptors. AJR Am J Roentgenol (1990) 0.84
Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging. Radiology (1991) 0.82
3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans. J Cereb Blood Flow Metab (1989) 0.82
Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease. Hum Gene Ther (2000) 0.78
Positron emission tomography (PET) imaging of tumor-localized Salmonella expressing HSV1-TK. Cancer Gene Ther (2005) 1.03
Cytoplasmically retargeted HSV1-tk/GFP reporter gene mutants for optimization of noninvasive molecular-genetic imaging. Neoplasia (2003) 0.99
Imaging expression of cytosine deaminase-herpes virus thymidine kinase fusion gene (CD/TK) expression with [124I]FIAU and PET. Mol Imaging (2003) 0.90
Assessment of treatment response by autoradiography with (14)C-aminocyclopentane carboxylic acid, (67)Ga-DTPA, and (18)F-FDG in a herpes simplex virus thymidine kinase/ganciclovir brain tumor model. J Nucl Med (2003) 0.86
Imaging of dihydrofolate reductase fusion gene expression in xenografts of human liver metastases of colorectal cancer in living rats. Eur J Nucl Med Mol Imaging (2003) 0.75